Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC

NCT00859339 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Patient Toxicities

Conditions

Transitional Cell Carcinoma of the Bladder

Interventions

DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Sunitinib Malate
PROCEDURE: Radical Cystectomy

Sponsor

Noah Hahn, M.D.

Collaborators

[object Object]
[object Object]